Present and future uses of hemoperfusion with sorbents.
D000284:Administration, Oral; D000327:Adsorption; D000818:Animals; D001772:Blood Cell Count; D001792:Blood Platelets / Q000166:cytology; D002606:Charcoal / Q000008:administration & dosage / Q000627:therapeutic use; D003128:Coma / Q000139:chemically induced / Q000628:therapy; D003404:Creatinine / Q000097:blood; D005544:Forecasting; D006464:Hemoperfusion / Q000295:instrumentation / Q000379:methods*; D006501:Hepatic Encephalopathy / Q000628:therapy; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D008727:Methotrexate / Q000097:blood; D011041:Poisoning / Q000188:drug therapy / Q000628:therapy; D012117:Resins, Synthetic; D014508:Urea / Q000097:blood; D014511:Uremia / Q000628:therapy
D006993:Hypnotics and Sedatives; D012117:Resins, Synthetic; D002606:Charcoal; D014508:Urea; D003404:Creatinine; D008727:Methotrexate